Loading…
Loading…
EQUITY / NASDAQ · XNCM
Advanced Biomed Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗6.24 USD · -1.2658%
Observed: Sep 30, 2026, 9:02 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
09/30/2026 · 6.23 USD · Volume 14,199
395 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2026 – 03/31/2026 · Units
| Metric | 2026 / Quarter 3 | 2025 / Quarter 3 | Change |
|---|---|---|---|
| Net income | -488,942 USD | -1,383,874 USD | — |
| Total assets | 10,646,324 USD | — | — |
| Total equity | 9,209,737 USD | 4,129,783 USD | +123.01% |
| Total liabilities | 1,436,587 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 1ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Net incomeIncome statement | -488,942 USD | 5,982,078 USD | 6,857,921 USD | 6,471,020 USD | -386,901 USD | — | -3,258,969 USD | -1,383,874 USD |
| Total assetsBalance sheet | 10,646,324 USD | — | 10,850,712 USD | — | 6,242,970 USD | 13,717,716 USD | 6,512,343 USD | — |
| Total equityBalance sheet | 9,209,737 USD | — | 9,481,642 USD | — | 3,004,124 USD | 3,477,564 USD | 3,477,564 USD | 4,129,783 USD |
| Total liabilitiesBalance sheet | 1,436,587 USD | — | 1,369,070 USD | — | 3,238,846 USD | 10,240,152 USD | 3,034,779 USD | — |
| Capital expendituresCash flow statement | — | 15,941 USD | — | 14,677 USD | 1,771 USD | — | 31,650 USD | — |
| Financing cash flowCash flow statement | — | 1,031,216 USD | — | 762,939 USD | 447,462 USD | — | 5,934,301 USD | — |
| Investing cash flowCash flow statement | — | -15,941 USD | — | -14,677 USD | -1,771 USD | — | -31,650 USD | — |
| Operating cash flowCash flow statement | — | -1,363,675 USD | — | -1,123,900 USD | -610,342 USD | — | -5,825,055 USD | — |
| Report source | Open report ↗ Published: 05/15/2026 | Open report ↗ Published: 05/15/2026 | Open report ↗ Published: 02/13/2026 | Open report ↗ Published: 02/13/2026 | Open report ↗ Published: 11/19/2025 | Open report ↗ Published: 05/15/2026 | Open report ↗ Published: 10/08/2025 | Open report ↗ Published: 05/15/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.